These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21819432)

  • 1. The importance of tricuspid regurgitation and right ventricular overload in ICD/CRT recipients: beside the left, beyond the left.
    Fazio S; Carlomagno G
    Pacing Clin Electrophysiol; 2011 Oct; 34(10):1181-4. PubMed ID: 21819432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible harmful effect of implantable cardioverter-defibrillator (ICD) lead placement on tricuspid valve function.
    Littmann L; Narveson SY; Fesel NM
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):499; author reply 501. PubMed ID: 22360631
    [No Abstract]   [Full Text] [Related]  

  • 4. Possible harmful effect of implantable cardioverter-defibrillator (ICD) lead placement on tricuspid valve function.
    Lim S
    Pacing Clin Electrophysiol; 2012 Apr; 35(4):500; author reply 501. PubMed ID: 22229307
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time Course and Predictors of Worsening Tricuspid Regurgitation Following Right Ventricular Lead Implantation.
    Markman TM; Kuo L; Mustin E; Amankwah NA; Supple GE; Dixit S; Nazarian S; Arkles J; Hyman M; Lin D; Epstein AE; Santangeli P; Deo R; Schaller RD; Frankel DS
    Circ Arrhythm Electrophysiol; 2020 Nov; 13(11):e009177. PubMed ID: 33035081
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy: device-based medicine for heart failure.
    Philippon F
    J Card Surg; 2004; 19(3):270-4. PubMed ID: 15151661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute hemodynamic effects of right and left ventricular lead positions during the implantation of cardiac resynchronization therapy defibrillators.
    Stockinger J; Staier K; Schiebeling-Römer J; Keyl C
    Pacing Clin Electrophysiol; 2011 Nov; 34(11):1537-43. PubMed ID: 21797906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRT plus ICD in congestive heart failure. Use of cardiac resynchronization therapy and an implantable cardioverter-defibrillator in heart failure patients with abnormal left ventricular dysfunction.
    Aronow WS
    Geriatrics; 2005 Feb; 60(2):24, 26-8. PubMed ID: 15742919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
    Yoda M; Tanabe H; Kishi M; Suma H
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
    Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
    Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study.
    Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ;
    Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of tricuspid prostheses].
    Ben-Ismail M; Curran Y; Bousnina A
    Arch Mal Coeur Vaiss; 1981 Sep; 74(9):1035-44. PubMed ID: 6794514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications and potential benefits of implantable automatic defibrillator endowed with biventricular pacing].
    Ansalone G; Ricci R; Cacciatore G; Santini M
    Ital Heart J Suppl; 2001 Dec; 2(12):1308-14. PubMed ID: 11838353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.
    Soliman OI; Theuns DA; van Dalen BM; Vletter WB; Nemes A; Jordaens LJ; Balk AH; Ten Cate FJ; Geleijnse ML
    Am J Cardiol; 2010 Jan; 105(1):105-11. PubMed ID: 20102900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.
    Pouleur AC; Knappe D; Shah AM; Uno H; Bourgoun M; Foster E; McNitt S; Hall WJ; Zareba W; Goldenberg I; Moss AJ; Pfeffer MA; Solomon SD;
    Eur Heart J; 2011 Jul; 32(14):1720-9. PubMed ID: 21609974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA; Abraham WT; Young JB; Johnson KM;
    Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.